A Study to Evaluate the Effects of ABX-1431 on Patients With Functional Dyspepsia

NCT02875678 · clinicaltrials.gov ↗

PHASE1

Phase

TERMINATED

Status

4

Enrollment

INDUSTRY

Sponsor class

Stopped recruitment challenges

Conditions

Dyspepsia

Interventions

DRUG: ABX-1431
DRUG: Placebo

Sponsor

Abide Therapeutics